At the news
? NEUTRALIMPACT 5/10 8-K filed Apr 21, 2026 at 08:00 ET
Pulmatrix, Inc. closed a $1 million private placement of Series B Preferred Stock with an affiliate of Eos SENOLYTIX, Inc. as part of its planned merger. The preferred shares are convertible into common stock at $2.20 per share and carry voting rights.
- Pulmatrix closed a private placement of Series B Preferred Stock on April 16, 2026
- The offering raised approximately $1 million in gross proceeds
- The investment was made by an affiliate of Eos SENOLYTIX, Inc.
- The Series B Preferred Stock is convertible into common stock at $2.20 per share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access